Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Abilify ODT
Active Ingredient: Aripiprazole 10mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Product: Abilify ODT
Active Ingredient: Aripiprazole 15mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Product: Abilify ODT
Active Ingredient: Aripiprazole 20mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Product: Abilify ODT
Active Ingredient: Aripiprazole 30mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Product: MOOV Head Lice Solution
Active Ingredients: Eucalyptus oil 11%w/w
Lemon Tea Tree Oil 1%w/w
Dosage Form: Solution
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Ego Pharmaceuticals Pty Limited, Braeside, Victoria, Australia
Product: Sumagran Active
Active Ingredient: Sumatriptan succinate 70mg equivalent to Sumatriptan 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Genpharm Inc., Etobicoke, Ontario, Canada
Dated this 19th day of April 2007.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).